Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries’ board has approved the estimated budget for the fiscal year (FY) 2024/2025 with expected net profits after tax of EGP 377 million, according to a filing on July 2nd.

This is compared to net profits of EGP 225 million in FY 2023/2024.

The firm also expected revenues of EGP 2.735 billion this FY.

It is worth noting that the company has reported a 67% annual surge in its net profits after tax in the first nine months of FY 2022/2023.

Alexandria Pharmaceuticals, an affiliated company of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary and nutritional food products, as well as medical appliances such as adhesive plasters, dental cartridges, medicated adhesive tapes, sterile gauze dressing, and surgical gloves.

Abu Qir Fertilizers approves FY2024/25 planning budget with estimated EGP18.6B sales Updated 6/27/2024 9:41:00 AM

AMOC approves FY2024/25 planning budget with EGP 660M in net profits Updated 6/25/2024 9:54:00 AM

Parliament gives final nod to FY2024/25 economic, social development plan Updated 6/4/2024 7:06:00 AM

Redcon Properties’ Chairman joins United Nations Global Compact board Updated 5/21/2024 4:05:00 PM

FRA thumbs up capital raise for Alexandria Container Updated 5/8/2024 10:29:00 AM